Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2026)

Cytek Biosciences filings provide 5 years of Asset Utilization Ratio readings, the most recent being 0.42 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 4.12% to 0.42 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.42, a 4.12% increase, with the full-year FY2025 number at 0.42, up 3.96% from a year prior.
  • Asset Utilization Ratio hit 0.42 in Q4 2025 for Cytek Biosciences, up from 0.4 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q4 2025 to a low of 0.0 in Q4 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.37 (2023), compared with a mean of 0.29.
  • The widest YoY moves for Asset Utilization Ratio: up 6674.42% in 2022, down 27.79% in 2022.
  • Cytek Biosciences' Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 6674.42% to 0.32 in 2022, then increased by 18.23% to 0.38 in 2023, then grew by 6.28% to 0.4 in 2024, then rose by 4.12% to 0.42 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.42 (Q4 2025), 0.4 (Q3 2025), and 0.4 (Q2 2025) per Business Quant data.